Table 2.
t1 | t2 | t3 | t4 | t5 | t6 | p | |
C-reactive protein (mg/l) | |||||||
Group A | 3.7 (1.0–22.6) | 79.9 (50.0–131.7) | 112.0 (61.1–177.6) | <0.001† | |||
Group B | 2.6 (0.6–10.5) | 87.6 (52.4–143.0) | 131.0 (71.0–228.0) | <0.001† | |||
p = 0.068* | p = 0.092* | p = 0.168* | |||||
IL-6 (pg/ml) | |||||||
Group A | 1.6 (0.4–21.8) | 95.0 (13.6–405.1) | 46.3 (16.1–149.5) | <0.001† | |||
Group B | 2.0 (0.4–60.6) | 130.5 (21.7–353.8) | 49.2 (14.8–214.5) | <0.001† | |||
p = 0.107* | p = 0.829* | p = 0.482* | |||||
IL-6r (ng/ml) | |||||||
Group A | 43.6 (1.7–125.0) | 47.4 (0.7–109.5) | 56.2 (25.2–226.3) | 0.949† | |||
Group B | 40.7 (15.6–94.6) | 42.4 (22.2–100.5) | 50.2 (13.2–104.9) | 0.861† | |||
p = 0.607* | p = 0.914* | p = 0.304* | |||||
IL-10 (pg/ml) | |||||||
Group A | 1.9 (0.2–24.0) | 47.2 (2.3–476.6) | 7.2 (1.3–90.9) | <0.001† | |||
Group B | 2.6 (0.8–9.7) | 209.7 (16.3–814.3) | 56.1 (3.6–225.1) | <0.001† | |||
p = 0.136* | p = 0.001* | p = 0.001* | |||||
Soluble endothelial leukocyte adhesion molecule-1 (ng/ml) | |||||||
Group A | 88.6 (49.8–194.5) | 88.5 (14.4–189.6) | 72.7 (8.9–163.1) | 0.058† | |||
Group B | 49.0 (18.3–144.1) | 130.7 (33.0–360.7) | 72.6 (16.7–224.7) | <0.001† | |||
p < 0.001* | p = 0.033* | p = 0.957* | |||||
Cardiac troponin-I (ng/ml) | |||||||
Group A | 0.02 (0.01–0.022) | 0.22 (0.07–0.85) | 0.13 (0.03–0.75) | <0.001† | |||
Group B | 0.01 (0.01–0.016) | 0.66 (0.10–1.28) | 0.19 (0.03–0.80) | <0.001† | |||
p = 0.520* | p = 0.018* | p = 0.097* |
Data presented as the median (range). t1, before anaesthesia; t2, 10 minutes after cardiac surgery on cardiopulmonary bypass (CPB); t3, 2 hours after CPB; t4, 4 hours after CPB; t5, 24 hours after CPB; t6, 44 hours after CPB. †Intraindividual differences (Friedman test), *between-group differences (Kruskal–Wallis test).